REQUEST A QUOTE
The AXIOM 20 3D printer is FDA validated for clinical use. It is used by several medical manufacturers, including Adaptive – a pioneer in the area of cancer treatment. Adaptiiv has received FDA approval for the production of it 3D printed medical devices. You can read more the approval by the Food and Drug Administration here.
“We have seen significant demand from our clients for information pertaining to 3D Bolus, Adaptiiv’s solution that enables the creation of customized 3D personal medical devices using 3D printing, used primarily in the treatment of cancer,” said Jordan Johnson, Director of Compliance at Churchill Consulting.
“Adaptiiv Medical Technologies Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market 3D Bolus Software. The company also has a CE Mark, ISO 13485 and TGA (Australia) approvals for its advanced software solution that enables the creation of customized personal medical devices using 3D printing.”
Adaptiiv’s technology solution uses AXIOM 20 3d printers to offer patient specific treatment to even the most difficult patient cases. With an AXIOM 20, oncologists can:
Advanced software accurately modulates the bolus model based on the Planning Target Volume and creates a single 3d printed device for the entire treatment regimen. Using Airwolf 3d equipment, physicists can:
Design, 3D print, and fit patient devices that provide more accurate results while eliminating manual fabrication methods and decreasing set-up time.
To learn about 3d printing medical devices or to start incorporation this technology into your treatment, contact Adaptiv here: https://www.adaptiiv.com/
To learn more about the 3d printer with FDA clearance, the AXIOM 20, click here.